CLINICAL_TRIALS trial_result · 2013-01-29

Clinical Trial Update: Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis [Phase 3]

A multicenter Phase 3 trial evaluated the safety and efficacy of NAFT-500 for treating tinea pedis (athlete's foot); results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merz North America, Inc. | Conditions: Tinea Pedis, Athlete's Foot | Phase 3 | Status: COMPLETED | Results posted: 2013-01-29